STOCK TITAN
  1. Home
  2. MYOK

MyoKardia (MYOK) Stock Price, News & Analysis

MYOK NASDAQ

Company Description

MyoKardia (NASDAQ: MYOK) is classified in the pharmaceuticals: other industry within the Health Technology sector.

This page collects what Stock Titan holds for MYOK, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
0.00%
0.00
Last updated:
-
Performance 1 year
$0.0
Market Cap
53.3M
Shares outstanding

Latest News

View All
+0.05%

MyoKardia Presents Cardiac Imaging Data from 30-Week EXPLORER-HCM Study of Mavacamten

+0.03%

MyoKardia Presents Mavacamten Clinical and Non-Clinical Data at the American Heart Association’s Scientific Sessions 2020

clinical trial
-0.06%

MyoKardia Collaborates with the American College of Cardiology and PINNACLE/Veradigm to Launch Patient Registry of Hypertrophic Cardiomyopathy

0.00%

MyoKardia Reports Third Quarter 2020 Financial Results

earnings
+0.48%

MyoKardia Announces Awardees of the Second Annual MyoSeeds™ Research Grants Program

-0.11%

MyoKardia Announces Multiple Abstracts Selected for Presentation at the Upcoming American Heart Association’s Annual Scientific Sessions 2020

conferences

MyoKardia has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 3 with negative movement. Key topics include clinical trial, earnings, conferences, partnership. View all MYOK news →

SEC Filings

View All

No SEC filings available for MYOK.

Financial Highlights

—
Revenue (latest FY)
—
Net Income (latest FY)
—
Diluted EPS (latest FY)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

MYOK Company Profile & Sector Positioning

MyoKardia (MYOK) operates in the Pharmaceuticals: Other industry within the broader Health Technology sector and is listed on the NASDAQ.